As expected: Nice consolidation today - which is very important ! : )
-----------------------------------------------------------------------------------------------------------------------
OODH -
I contacted OTC Markets.com again this morning on behalf of the few shareholders who use that website, as many do not use that service. (212) 896-4420
In addition, several OODH shareholders wanted to know if we could keep the "Skull & Cross Bones" after financials get posted on that private website. I agree it is a cool image! Lol
Unfortunately, after speaking with the OTC Markets they will not allow OODH to keep the Skull & Cross Bones once we upload the CPA's copy of the financials. Sorry guys!
OODH
Since they won't let us keep the Skull & BS we have requested OTC Markets use this image for OODH instead:
Hope you like it !
I am still awaiting for their response as we speak! Lol
(j/k BTW)
NOTE: If you do use that private website for key company information and updates, just watch it and see what happens in the near future. Thanks
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Oh...and... it would have also been sweet to have the S& BS during Halloween... but the Skull will be gone LONG before that holiday arrives! Again sorry guys! I tried, I really did! LOL
Nice consolidation today -
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Revolutionary AI Improves Immunology and Cancer Research Efficiency
Transforming Research with AI Technology BD (Becton, Dickinson and Company) (NYSE: BDX) has recently launched an innovative tool that is set to transform the landscape of immunology and cancer research. The introduction of the BD® Research Cloud 7.0, featuring the BD Horizon™ Panel Maker, is redefining how scientists approach experimental design in these critical...
Continue Reading
Strategic Collaboration of IONETIX and AlfaRim Medical Unveiled
Strategic Partnership Between IONETIX and AlfaRim Medical In a significant move within the medical isotope industry, IONETIX Corporation has announced a strategic partnership with AlfaRim Medical B.V. This collaboration sets the stage for accelerating the commercial production of Actinium-225, a crucial isotope used in targeted alpha therapies for various cancers. As...
Continue Reading
Endeavour Silver's Terronera Project Achieves Major Milestones
Endeavour Silver's Terronera Project Update: Key Developments Endeavour Silver Corp. (NYSE: EXK; TSX: EDR) has unveiled a significant third-quarter construction progress report for its Terronera Project located in Mexico. The company takes pride in its remarkable strides toward achieving full operational readiness. Progress Overview The Terronera Project has progressed...
Continue Reading
Healthcare Sector Faces Major Cybersecurity Challenges Amid Breaches
Significant Rise in Healthcare Data Breaches In the healthcare industry, data breaches hit a dramatic peak, leading to an alarming tally of over 276 million records compromised. This stunning figure represents a staggering 64.1% increase from prior years, illustrating profound vulnerabilities in the protection of sensitive patient information. As such, the harsh reality...
Continue Reading
Tempus AI Investors Prepare for Class Action Opportunity
Understanding the Tempus AI Class Action Lawsuit Investors in Tempus AI, Inc. (NASDAQ: TEM) may find themselves in a position to lead a class action lawsuit following substantial financial losses. This legal opportunity arises from significant allegations against the company, which purports to be advancing precision medicine through artificial intelligence. Who Can...
Continue Reading